You just read:

Mirati Therapeutics Presents Positive Preliminary Data From On-Going Clinical Trials Of Sitravatinib In Non-Small Cell Lung Cancer

News provided by

Mirati Therapeutics, Inc.

Sep 14, 2017, 16:32 ET